See Also: Late HIV Diagnosis and Treatment, Starting HIV Treatment

Selected Recent Articles

• Prompt ART reduces HIV patients’ cancer risk.  (September 2016, Healio)
• START analysis looks at who benefits most from immediate HIV treatment.  (August 2016, AIDSmap)
• Small risk of sexual transmission of HIV persists through first six months of ART.  (May 2016, AIDSmap)
• Almost Half Regain Ability to Work Within 1 Year of Starting Treatment.  (April 2016, The BodyPro)
• HIV Meds Have Prevented Opportunistic Infections on a Massive Scale in Poorer Nations.  (April 2016, Poz); related coverage from Healio and Science Speaks Blog
• No adverse social consequences from early ART initiation in West Africa.  (April 2016, AIDSmap)
• ‘Explosion of options’ in single-tablet regimens for HIV benefits patients, providers.  (March 2016, Healio)
• Starting HIV Treatment May Improve Liver Health.  (March 2016, Poz)
• START study shows that people starting HIV treatment earlier have better quality of life.  (March 2016, AIDSmap)
• Early antiretroviral therapy reduces the risk of infection-related cancers. (February 2016, AIDSmap); related coverage from Poz
• Starting HIV treatment at first clinic visit improves outcomes in African study. (February 2016, AIDSmap)
• Benefits of early HIV treatment are clear, but issues raised by START and D:A:D remain unresolved.  (October 2015, AIDSmap)
• Several Cancers Pose Greater Risk to People With HIV.  (October 2015, Poz)
• Substantial improvement in life expectancy of older HIV-positive patients in modern treatment era, report Danes.  (September 2015, AIDSmap)
• Same-day start to antiretroviral treatment leads to faster HIV suppression in San Francisco.  (July 2015, AIDSmap)
• As HPTN 052 ends, Dr. Cohen confirms findings with new insights.  (July 2015, Science Speaks Blog)
• HIV Remission for More Than 12 Years After Very Early Treatment in French Teenager.  (July 2015, TheBodyPro)
• The Day the HIV Treatment Pendulum Stopped Swinging.  (July 2015, TheBodyPro)
• Early HIV Treatment’s Benefits Examined More Closely.  (July 2015, Poz)
• START trial provides definitive evidence of the benefits of early HIV treatment.  (July 2015, AIDSmap)
• While “game-changing,” START trial draws “line in the sand” and sets “time a’ ticking” to stop preventable illnesses and death, calls for action are accompanied by questions of impact of inequities, obstacles.  (July 2015, Science Speaks Blog)
• Achieving Long-Term HIV Suppression Could Be Easier Than Expected.  (July 2015, Poz)
• Early HIV Treatment Especially Benefits Older People.  (July 2015, Poz)
• Prompt ART especially important for people with HIV aged 45 and over.  (July 2015, AIDSmap)
• In Africa, Increasing HIV Treatment Appears to Lower Stigma.  (June 2015, Poz)
• HIV Mortality Risk Remains High Despite Decrease Over 30 Years.  (June 2015, TheBodyPro).
• Early ART proves more beneficial than deferred treatment.  (May 2015, Healio)
• Solid Evidence Backing Early HIV Treatment Finally Arrives.  (May 2015, Poz)
• START trial finds that early treatment improves outcomes for people with HIV.  (May 2015, AIDSmap)
• Men taking HIV treatment have undetectable viral loads in the rectum; sexually transmitted infections make no difference.  (April 2015, AIDSmap)
• Early antiretroviral treatment reduces, but does not eliminate HIV reservoir.  (March 2015, AIDSmap)
• Starting HIV treatment early leads to better health and improved immune systems.  (March 2015, Project Inform)
• ART soon after infection linked to better CD4 recovery through 10 years.  (March 2015, NATAP)
• Early initiation of ART, sustained virological suppression reduced reservoir size.  (February 2015, Healio)
• Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows.  (February 2015, AIDSmap)
• Early antiretroviral treatment reduces seizure risk by two-thirds for children with HIV.  (February 2015, AIDSmap)
• Starting HIV treatment early and then interrupting is no better than delaying it.  (January 2015, AIDSmap)
• Waiting a Year to Start HIV Meds Could Hurt Chances for “Normal” CD4 Count.  (January 2015, TheBody)
• First Year After HIV Infection Is Key Window for Treatment Start.  (January 2015, Poz)
• ART during tuberculosis therapy reduces mortality risk for people with HIV.  (December 2014, AIDSmap)
• HIV Meds Can Benefit Positive Gay Meth and Cocaine Users.  (October 2014, Poz)
• HIV, if Treated, May Not Raise Cognitive Impairment Risk.  (August 2014, Poz)
• Inflammation/Activation Markers Drop With ATV, DRV, RAL, But Not Completely – ACTG Study.  (July 2014, NATAP)
• Major Study Supports Benefits of Beginning HIV Therapy Early.  (May 2014, Poz)
• Early antiretroviral treatment reduces risk of AIDS and HIV-related illness. (May 2014, AIDSmap)
• Benefits of a Lowered HIV Pill Burden and Dosing Schedule.  (April 2014, Poz)
• HIV Meds Greatly Benefit South Africans, But Favor Women.  (March 2014, Poz)
• Brain Markers of Inflammation Drop to Normal With Early ART. (March 2014, NATAP)
• Older age associated with bigger increases in viral load and falls in CD4 count in patients not taking HIV treatment.  (February 2014, AIDSmap)
• Life expectancy now considerably exceeds the average in some people with HIV in the US.  (January 2014, AIDSmap)
• ARVs Lower Advanced Liver Disease in Men With HIV & Hep C.  (January 2014, Poz)
• Short course of ART during primary HIV infection has immunological and virological benefits after treatment is stopped.  (December 2013, AIDSmap)
• Life Expectancy for Young People With HIV Is Nearly Normal.  (December 2013, Poz)
• Starting antiretroviral therapy significantly reduces the risk of decompensated liver disease for men with HIV/HCV co-infection.  (December 2013, AIDSmap)
• HIV treatment in South Africa has had “astounding” benefits.  (December 2013, AIDSmap)
• Most MSM Who Transmit Drug-Resistant HIV Are Not on Treatment.   (November 2013, CDC)
• Early Treatment and Weight Management May Prevent Common HIV Comorbidities.  (November 2013, TheBodyPro)
• Low CD4 cell count increases heart attack risk for people with HIV.  (October 2013, AIDSmap)
• CD4 Cell Count at Presentation: A Figure With a Depressingly Small Upward Slope.  (October 2013, Journal Watch)
• Late HIV diagnosis continues to be a Europe-wide problem.  (September 2013, AIDSmap)
• Costs Spike for 2nd- and 3rd-Line ARVs and Late Treatment.  (September 2013, Poz)
• Insufficient Evidence to Support Universal HIV Treatment?  (August 2013, Poz)
• CD4 cell count at time of entry to HIV care did not increase significantly between 1992 and 2011.  (August 2013, AIDSmap)
• A 15-Year Jump in Life Expectancy for People With HIV.  (July 2013, Poz)
• Numerous Studies Show Benefit of Earlier HIV Treatment.  (July 2013, Poz)
• Starting treatment at a CD4 count above 500 reduces the HIV reservoir for people with long-term infection.  (July 2013, AIDSmap)
• WHO issues new HIV recommendations calling for earlier ARV initiation.  (June 2013, AIDSmap)
• Antiretroviral therapy cuts mortality risk for people diagnosed with HIV-related lymphoma.  (June 2013, AIDSmap)
• Prompt HIV diagnosis and early antiretroviral therapy especially important for older people.  (June 2013, AIDSmap)
• Early Treatment May Do More Harm Than Good in Poor Regions.  (June 2013, Poz)
• Low CD4 cell count increases the risk of several cancers after starting HIV therapy.  (June 2013, AIDSmap)
• Starting HIV Meds When CD4s Are Low Raises Cancer Risk.  (June 2013, Poz)
• Undetectable viral load reduces the risk of HIV-associated anal cancer.  (June 2013, AIDSmap)
• Success on HIV Therapy Means Normal Mortality Risk.  (June 2013, Poz)
• People doing well on HIV therapy have a mortality risk identical to that of HIV-negative peers.  (June 2013, AIDSmap)
• HIV Meds Protect Against Doubled Cancer Risk in Positive Men.  (May 2013, Poz)
• HIV Therapy May Protect Heart Function in Children and Teens.  (April 2013, Poz)
• Long-term suppression of viral load and sustained CD4 cell increase reduce risk of cervical HPV infection for HIV-positive women.  (April 2013, AIDSmap)
• Low CD4s, Not Viral Load, Increase Risk of Non-AIDS Diseases for Those Off Treatment.  (March 2013, Poz)
• No Excess Death Among HIV-Infected People – as Long as CD4+ Cell Counts Are Kept Close to Normal.  (March 2013, TheBodyPro)
• Short-Term Mortality After Heart Attack With HIV Fell Over Past Decade in D:A:D.  (March 2013, NATAP)
• Very early antiretroviral treatment limits the size of HIV reservoir. (March 2013, AIDSmap)
• Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop.  (February 2013, Poz)